Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Tibbo, P. Articles by Allen, P. Search for Related Content PubMed Citation Articles by Tibbo, P. Articles by Allen, P. Schizophrenia Spectrum Disorders Genetics MRS

3-T Proton MRS Investigation of Glutamate and Glutamine in Adolescents at High Genetic Risk for Schizophrenia

OBJECTIVE: Glutamate and glutamine were examined in vivo in nonpsychotic adolescents at high genetic risk for schizophrenia by using 3-T proton magnetic resonance spectroscopy (¹H-MRS). METHOD: Spectra from the right medial frontal lobe of 20 adolescents who had a parent with schizophrenia (high-risk group; mean age=16.4 years) were compared with spectra obtained from adolescent offspring of parents with no history of schizophrenia (low-risk group; mean age=16.7 years). RESULTS: Glutamate/glutamine was significantly higher in the adolescents at high genetic risk for schizophrenia than in the low-risk offspring. Age, premorbid adjustment scale scores, and other ¹H-MRS metabolites did not differ between groups. Global Assessment of Functioning Scale scores and socioeconomic status were lower in the high-risk group. DISCUSSION: The finding of glutamate/glutamine abnormalities in a group of subjects at high genetic risk for schizophrenia lends support for both the glutamate dysfunction and neurodevelopmental hypotheses for schizophrenia.

This article has been cited by other articles:

				J. THEBERGE, K. E. WILLIAMSON, N. AOYAMA, D. J. DROST, R. MANCHANDA, A. K. MALLA, S. NORTHCOTT, R. S. MENON, R. W. J. NEUFELD, N. RAJAKUMAR, et al. Longitudinal grey-matter and glutamatergic losses in first-episode schizophrenia The British Journal of Psychiatry, October 1, 2007; 191(4): 325 - 334. [Abstract] [Full Text] [PDF]

				R. E. Gur, M. S. Keshavan, and S. M. Lawrie Deconstructing Psychosis With Human Brain Imaging Schizophr Bull, July 1, 2007; 33(4): 921 - 931. [Abstract] [Full Text] [PDF]

				J. M. Stone, P. D. Morrison, and L. S. Pilowsky Review: Glutamate and dopamine dysregulation in schizophrenia a synthesis and selective review J Psychopharmacol, June 1, 2007; 21(4): 440 - 452. [Abstract] [PDF]

				J. Arehart-Treichel Glutamate Could Play Pivotal Role in Schizophrenia Psychiatr News, June 18, 2004; 39(12): 30 - 30. [Full Text]

Get information about faster international access.

Privacy Policy

Copyright © 2004 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us